Related Experiment Videos

Souter-Strathclyde total elbow arthroplasty

P Rozing1

  • 1Department of Orthopaedic Surgery, Leiden University Medical Centre, The Netherlands.

Insights

The Souter-Strathclyde elbow arthroplasty demonstrated a 69% survival rate at ten years. While pain relief was achieved in 67% at one year, long-term outcomes showed persistent pain in 64% of cases.

Area of Science:

  • Orthopedic Surgery
  • Biomaterials Science
  • Reconstructive Surgery

Background:

  • The Souter-Strathclyde elbow prosthesis was utilized between 1982 and 1993.
  • A review of 66 consecutive implants in 59 patients was conducted.

Purpose of the Study:

  • To evaluate the long-term outcomes and survival rates of the Souter-Strathclyde elbow arthroplasty.
  • To assess pain relief, range of motion, and complication rates associated with this prosthesis.

Main Methods:

  • Retrospective review of 66 Souter-Strathclyde elbow arthroplasties.
  • Kaplan-Meier survival analysis.
  • Assessment of pain, range of motion, and complications.

Main Results:

  • The 10-year survival probability was 69%.
  • Early complications included epicondyle fractures (9%) and ulnar neuropathy (33% post-op incidence).
  • At one year, 67% experienced pain relief; after 10+ years, 36% were pain-free, with 64% reporting occasional pain.

Conclusions:

  • The Souter-Strathclyde elbow prosthesis has a moderate long-term survival rate but is associated with significant rates of persistent pain and complications.
  • Further research into improving elbow arthroplasty outcomes is warranted.

Related Concept Videos